SK7702001A3 - Thiourea inhibitors of herpes viruses - Google Patents

Thiourea inhibitors of herpes viruses Download PDF

Info

Publication number
SK7702001A3
SK7702001A3 SK770-2001A SK7702001A SK7702001A3 SK 7702001 A3 SK7702001 A3 SK 7702001A3 SK 7702001 A SK7702001 A SK 7702001A SK 7702001 A3 SK7702001 A3 SK 7702001A3
Authority
SK
Slovakia
Prior art keywords
phenyl
carbon atoms
thioureido
chloro
ethyl
Prior art date
Application number
SK770-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Jonathan David Bloom
Kevin Joseph Curran
Martin Joseph Digrandi
Russell George Dushin
Stanley Albert Lang
Emily Boucher Norton
Adma Antonia Ross
Bryan Mark O'hara
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SK7702001A3 publication Critical patent/SK7702001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
SK770-2001A 1998-12-09 1999-12-06 Thiourea inhibitors of herpes viruses SK7702001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20856198A 1998-12-09 1998-12-09
PCT/US1999/028837 WO2000034238A1 (en) 1998-12-09 1999-12-06 Thiourea inhibitors of herpes viruses

Publications (1)

Publication Number Publication Date
SK7702001A3 true SK7702001A3 (en) 2002-04-04

Family

ID=22775050

Family Applications (1)

Application Number Title Priority Date Filing Date
SK770-2001A SK7702001A3 (en) 1998-12-09 1999-12-06 Thiourea inhibitors of herpes viruses

Country Status (26)

Country Link
EP (1) EP1137632B1 (es)
JP (1) JP2002531545A (es)
KR (1) KR20010089559A (es)
CN (1) CN1332725A (es)
AR (1) AR033789A1 (es)
AT (1) ATE272052T1 (es)
AU (1) AU1934500A (es)
BG (1) BG105583A (es)
BR (1) BR9916086A (es)
CA (1) CA2351403A1 (es)
CZ (1) CZ20011957A3 (es)
DE (1) DE69919023T2 (es)
DK (1) DK1137632T3 (es)
EA (1) EA200100634A1 (es)
ES (1) ES2224733T3 (es)
HU (1) HUP0104763A3 (es)
ID (1) ID30287A (es)
IL (1) IL143262A0 (es)
NO (1) NO20012838L (es)
NZ (1) NZ512108A (es)
PL (1) PL348178A1 (es)
PT (1) PT1137632E (es)
SK (1) SK7702001A3 (es)
TR (1) TR200101597T2 (es)
WO (1) WO2000034238A1 (es)
ZA (1) ZA200104144B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
WO2001064642A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
DE10217518A1 (de) * 2002-04-19 2003-11-06 Bayer Ag Lactone
DE10222024A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Lactame
DE10257786A1 (de) * 2002-12-11 2004-07-01 Bayer Healthcare Ag Oxazolidinone
CN101595092B (zh) 2006-11-02 2012-02-01 米伦纽姆医药公司 合成因子xa抑制剂的医药盐的方法
WO2012162291A1 (en) * 2011-05-24 2012-11-29 The Wistar Institute Compositions and methods for modulating the activity of epstein-barr nuclear antigen 1
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
JP6372666B2 (ja) 2012-11-03 2018-08-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害剤
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
CN118076593A (zh) * 2021-09-07 2024-05-24 上海齐鲁制药研究中心有限公司 3CLpro蛋白酶抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
HUP0004421A3 (en) * 1996-04-23 2002-10-28 Vertex Pharmaceuticals Inc Cam Urea derivatives and pharmaceutical compositions containing them, use thereof for the treatment of deseases mediated by impdh enzyme

Also Published As

Publication number Publication date
EP1137632A1 (en) 2001-10-04
EA200100634A1 (ru) 2001-10-22
PT1137632E (pt) 2004-11-30
CN1332725A (zh) 2002-01-23
CA2351403A1 (en) 2000-06-15
HUP0104763A3 (en) 2005-04-28
KR20010089559A (ko) 2001-10-06
CZ20011957A3 (cs) 2001-10-17
BR9916086A (pt) 2001-09-04
NZ512108A (en) 2003-09-26
HUP0104763A2 (hu) 2002-04-29
WO2000034238A1 (en) 2000-06-15
JP2002531545A (ja) 2002-09-24
EP1137632B1 (en) 2004-07-28
NO20012838D0 (no) 2001-06-08
PL348178A1 (en) 2002-05-06
AU1934500A (en) 2000-06-26
ES2224733T3 (es) 2005-03-01
IL143262A0 (en) 2002-04-21
ATE272052T1 (de) 2004-08-15
AR033789A1 (es) 2004-01-07
NO20012838L (no) 2001-08-08
DK1137632T3 (da) 2004-11-01
ID30287A (id) 2001-11-15
DE69919023D1 (de) 2004-09-02
TR200101597T2 (tr) 2001-10-22
ZA200104144B (en) 2002-08-21
BG105583A (en) 2001-12-29
DE69919023T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
CZ20012060A3 (cs) Thiomočovinové sloučeniny obsahující acetamid a substituovaný acetamid jako inhibitory herpes virů
SK7682001A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
SK7702001A3 (en) Thiourea inhibitors of herpes viruses
CZ20012063A3 (cs) Thiomočovinové sloučeniny obsahující heterocyklický karboxamid a substituovanou fenylendiaminovou skupinu jako inhibitory herpes virů
CZ20012067A3 (cs) Thiomočovinové sloučeniny obsahující alfa methylbenzylovou skupinu a fenylendiaminovou skupinu jako inhibitory herpes virů
CZ20012057A3 (cs) Thiomočovinové sloučeniny jako inhibitory herpes virů 199
SK7692001A3 (en) Thiourea inhibitors of herpes viruses
US6197803B1 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
MXPA01005679A (es) Tioureas que contienen carboxamidas heterociclicas y el grupo fenilendiamina, como inhibidores de herpes virus
MXPA01005835A (es) Inhibidores de tiourea de virus del herpes
MXPA01005829A (es) Inhibidores de tiourea de virus del herpes
MXPA01005681A (es) Tioureas que contienen alfa -metilbencilo y el grupo fenilendiamina como inhibidores de los herpes virus
KR20010087416A (ko) 페닐렌디아민기를 함유하는 헤르페스 바이러스의헤테로시클릭 카르복사미드-함유 티오우레아 저해제
MXPA01005827A (es) Inhibidores de tiourea de virus del herpes
MXPA01005680A (es) Tioureas que contienen acetamidas y acetamida sustituida como inhibidores de herpes virus
MXPA01005828A (es) Inhibidores de virus del herpes a base de tiourea que contiene carboxamida heterociclica, y un grupo fenilendiamina substituido